ResearcherChinese Academy of SciencesNo recent work listed
Yanli Yao
Matched on ORCID iD 0000-0002-1850-8780; OpenAlex author ID A5025744343. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2017: 1 paper · 2018: none · 2019: 1 paper
Papers 2
- HH1-1, a novel Galectin-3 inhibitor, exerts anti-pancreatic cancer activity by blocking Galectin-3/EGFR/AKT/FOXO3 signaling pathway. Co-author DOI 10.1016/j.carbpol.2018.10.008↗
- A Concise Synthesis of Three Branches Derived from Polysaccharide RN1 and Anti-Pancreatic Cancer Activity Study. First author DOI 10.3390/polym9100536↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kan Ding · 2 shared papers, 2017–2019 · strength 0.18
- Paper HH1-1, a novel Galectin-3 inhibitor, exerts anti-pancreatic cancer activity by blocking Galectin-3/EGFR/AKT/FOXO3 signa… DOI 10.1016/j.carbpol.2018.10.008↗
- Paper A Concise Synthesis of Three Branches Derived from Polysaccharide RN1 and Anti-Pancreatic Cancer Activity Study. DOI 10.3390/polym9100536↗
- Chenghao Shao · 1 shared paper, 2019 · strength 0.10
- Deqin Cai · 1 shared paper, 2017 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.